metab iv adrenal)

Upload: ethel-lourdes-cornejo-amodia

Post on 14-Apr-2018

232 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/2/2019 Metab IV Adrenal)

    1/119

    Hormones

  • 8/2/2019 Metab IV Adrenal)

    2/119

    Anterior Pituitary Disorders

    Acromegaly

    Excessive growth hormone (GH)

  • 8/2/2019 Metab IV Adrenal)

    3/119

    Risk factors

    None

    Etiology

    Anterior Pituitary adenoma; abnormalhypothalamic function (rare)

    May demonstrate hyperglycemia; inacromegaly, GH level remains increased.

  • 8/2/2019 Metab IV Adrenal)

    4/119

    Diagnostic Procedures

    X-ray

    x-ray of the skull may show thickening of thebones and enlargement of the nasal sinuses

    x-rays of the hands show thickening of the

    bones under the fingertips and swelling of thetissue around the bones

    Blood Test

    The diagnosis is confirmed by blood tests,which usually show high levels of both growthhormone and insulin-like growth factor

  • 8/2/2019 Metab IV Adrenal)

    5/119

    CT Scan

    usually done to look for abnormal growths inthe pituitary gland

    Because acromegaly is usually present forsome years before being diagnosed, a tumoris seen on these scans in most people.

  • 8/2/2019 Metab IV Adrenal)

    6/119

    Clinical Manifestations

    excessive production of growth hormone begins betweenthe ages of 30 and 50, long after the growth plates of thebones have closed

    Bones become deformed rather than elongated

    Facial features become coarse, and the hands and feetswell

    Overgrowth of the jawbone (mandible) can cause the jawto protrude (prognathism).

    Cartilage in the voice box (larynx) may thicken, making thevoice deep and husky.

    The ribs may thicken, creating a barrel chest.

    Joint pain The tongue may enlarge and become more furrowed

    Coarse body hair, which typically darkens, increases asthe skin thickens

  • 8/2/2019 Metab IV Adrenal)

    7/119

    The sebaceous and sweat glands in the skin enlarge,producing excessive perspiration and often an offensive bodyodorThe heart usually enlarges, and its function may be so

    severely impaired that heart failure occursSometimes a person feels disturbing sensations andweakness in the arms and legs as enlarging tissues compressthe nervesNerves that carry messages from the eyes to the brain may

    also be compressed, causing loss of vision, particularly in theouter visual fieldsThe pressure on the brain may also cause severe headaches.irregular menstrual cyclesProduction of breast milk even though not breastfeeding(galactorrhea) because of either too much growth hormone ora related increase in prolactinAbout one third of men who have acromegaly develop erectiledysfunctionLife expectancy is reduced in people with untreatedacromegaly

  • 8/2/2019 Metab IV Adrenal)

    8/119

  • 8/2/2019 Metab IV Adrenal)

    9/119

  • 8/2/2019 Metab IV Adrenal)

    10/119

  • 8/2/2019 Metab IV Adrenal)

    11/119

    Radiation therapy

    involves the use of supervoltage irradiation

    This treatment may take several years tohave its full effect, however, and oftenresults in later deficiencies of other pituitaryhormones, as normal tissue is often also

    affected

  • 8/2/2019 Metab IV Adrenal)

    12/119

    Drug therapy

    Also used to lower growth hormone levelsbromocriptine (Parlodel) and other drugs that act likedopamine

    somatostatin, the hormone that normally blocks

    growth hormone production and secretion octreotide (Sandostatin) which only have to be given

    about once a month

    These drugs are effective in controlling acromegaly in

    many people as long as they continue to be taken(they do not provide a cure)

  • 8/2/2019 Metab IV Adrenal)

    13/119

    Gigantism

    excessive secretion of growth hormone duringchildhood, before the closure of the bone

    growth plates

    excess growth hormone causes overgrowth ofthe long bones and very tall stature.

  • 8/2/2019 Metab IV Adrenal)

    14/119

    Causes

    benign pituitary gland tumor If excessive secretion of growth hormone

    occurs after normal bone growth has stopped,the condition is known as acromegaly

    The vertical growth in height that marks thiscondition is also accompanied by growth inmuscles and organs, which makes the child

    extremely large for his or her age. Thedisorder can also delay puberty

    Gigantism is very rare

  • 8/2/2019 Metab IV Adrenal)

    15/119

    Manifestations: Excessive growth during childhood

    Frontal bossing and a prominent jaw

    Thickening of the facial features

    Disproportionately large hands and feet with thickfingers and toes

    Increased perspiration

    Weakness

    Secretion of breast milk

    Irregular menstruation

    Headache

    Delayed onset of puberty

    Double vision or difficulty with peripheral vision

  • 8/2/2019 Metab IV Adrenal)

    16/119

  • 8/2/2019 Metab IV Adrenal)

    17/119

    Exams and Tests

    increase in insulin growth factor-I (IGF-I) levels failure to suppress serum growth hormone (GH)

    levels after an oral glucose challenge (maximum 75g)

    CT or MRI scan of the head showing pituitary tumor

    High prolactin levels Other hormone levels may be low due to damage to

    the pituitary, including thyroid hormone, testosterone(boys), stradiol (girls), or cortisol.

  • 8/2/2019 Metab IV Adrenal)

    18/119

    Treatment In pituitary tumors with well-defined borders, surgery is the

    treatment of choice and is curative is about 80% of cases. For situations in which surgery cannot completely remove

    the tumor, medication is the treatment of choice. The mosteffective medications are somatostatin analogs (such asoctreotide or long-acting lanreotide), which reduce growthhormone secretion.

    Dopamine agonists (bromocriptine mesylate, cabergoline)have also been used to reduce growth hormone secretion,but these are generally less effective.

    Radiation therapy has also been used to normalize growthhormone levels. However, it can take 5-10 years for the fulleffects to be seen and is almost always associated with

    deficiencies in other pituitary hormones. In addition,radiation has been associated with learning disabilities,obesity, and emotional changes in children. Most expertswill use radiation only if surgery and medication fail.

  • 8/2/2019 Metab IV Adrenal)

    19/119

    Possible Complications The development of secondary sexual

    characteristics may be delayed.

    Surgery and radiation can both lead todeficiencies in other pituitary hormones,causing hypothyroidism, adrenal insufficiency,hypogonadism, and (rarely) diabetes

    insipidus.

  • 8/2/2019 Metab IV Adrenal)

    20/119

    Dwarfism

    the result of the disproportionate growth of the skeleton.In most cases, dwarfism is genetically determined. We

    refer to those affected as "Little People." A dwarf is a person of short stature - under 4 10 as an

    adult.

    More than 200 different conditions can cause dwarfism.A single type, called achondroplasia, causes about 70

    percent of all dwarfism. Achondroplasia is a genetic condition that affects about

    1 in 25,000 people. It makes arms and legs short incomparison to the head and trunk. Other geneticconditions, kidney disease and problems withmetabolism or hormones can also cause short stature.

    Dwarfism itself is not a disease. However, there is agreater risk of some health problems. With propermedical care, most people with dwarfism have active

    lives and live as long as other people

  • 8/2/2019 Metab IV Adrenal)

    21/119

    Etiology

    Family history and parent's stature are usually notrelevant to the child's dwarfism.

    genetic mutations at the moment of conception random combination of two recessive genes that may

    have been dormant for generations

  • 8/2/2019 Metab IV Adrenal)

    22/119

    Signs and Symptoms

    In general, the disorders are divided into twobroad categories.

    Disproportionare dwarfismProportionate dwarfism

  • 8/2/2019 Metab IV Adrenal)

    23/119

    Disproportionate dwarfism

    If body size is disproportionate, some parts ofthe body are small and others are of averagesize or above-average size. Disorders causingdisproportionate dwarfism inhibit the

    development of bones.Characteristics: The person has an average-size trunk and very short

    limbs, but some people may have a very short trunkand shortened (but disproportionately large) limbs.

    The other common characteristic of these disorders isthe head being disproportionately larger than thebody.

  • 8/2/2019 Metab IV Adrenal)

    24/119

    Almost all people with disproportionate dwarfismhave normal intellectual capacities. Rareexceptions are usually the result of a secondary

    factor, such as excess fluid in the brain(hydrocephalus).

    About 70 percent of all people with dwarfismhave a disorder called chondroplasia, which

    causes disproportionately short stature. Thisdisorder usually results in:

  • 8/2/2019 Metab IV Adrenal)

    25/119

    An adult height of approximately 4 feet

    An average-size trunk Short arms and legs, with particularly short upper

    arms and legs

    Short fingers, often with a wide separation between

    the middle and ring fingers Limited mobility at the elbows

    A disproportionately large head, with a prominentforehead and flattened bridge of the nose

    Progressive development of bowed legs (genuvarum) Progressive development of swayed lower back

    (lordosis)

  • 8/2/2019 Metab IV Adrenal)

    26/119

    Proportionate dwarfism

    A body is proportionately small if all parts of the body

    are small to the same degree and appear to beproportioned like a body of average stature.

    Proportionate dwarfism results from medicalconditions present at birth or during early childhood

    that limit overall growth and development. Therefore,the head, trunk and limbs are all small but of averageproportions relative to each other.

    Most of these disorders are uncommon, and signs

    and symptoms of the disorders vary greatly. A fewdisorders causing proportionate dwarfism result inmental retardation.

  • 8/2/2019 Metab IV Adrenal)

    27/119

    Growth hormone deficiency is a relativelycommon cause of proportionate dwarfism. It

    occurs when the pituitary gland fails toproduce an adequate supply of growthhormone, which is essential for regularchildhood growth. Signs and symptoms

    include:Height below the fifth percentile on standardpediatric growth charts

    Slowed growth before age 5

    Periods of little or no change in height

    Adult height usually less than 5 feet

    Delayed or no sexual development duringadolescence

  • 8/2/2019 Metab IV Adrenal)

    28/119

  • 8/2/2019 Metab IV Adrenal)

    29/119

  • 8/2/2019 Metab IV Adrenal)

    30/119

  • 8/2/2019 Metab IV Adrenal)

    31/119

    Intervention

    The orthopaedic effects of dwarfism requirecomplex reconstructive surgery and extensive

    physical therapy. Much like the severeaccident victim, surgery on Little Peopleinvolves bone grafts, fusions, steel screws,pins and plates, then months of physical

    therapy to regain even the most basic functionlike walking.

  • 8/2/2019 Metab IV Adrenal)

    32/119

    Nursing Management

    Families of Little People sacrifice greatly toimprove the quality of their children's lives.Medical bills, transportation, multiplehospitalizations and operations, and months

    spent in casts can take their toll emotionally,economically, and physically on the entirefamily

    provide the family with the support they needto endure these trying times, knowing thattheir goals are attainable and worthwhile

  • 8/2/2019 Metab IV Adrenal)

    33/119

    Hypergonadism

    A clinical state resulting from enhanced

    secretion of gonadal hormones. A condition of increased hormone production

    before puberty, which produces precocioussexual development in both sexes.

  • 8/2/2019 Metab IV Adrenal)

    34/119

    Causes

    Male: Unknown causes, testicular tumors, andpituitary tumors.

    Female: primarily due to idiopathic causes.

    Uncommon causes include ovarian andadrenal tumors.

    Diagnosis

    Confirmed by positive clinical history bloodtesting for evidence of elevated sexhormones.

  • 8/2/2019 Metab IV Adrenal)

    35/119

    Male

    Onset of puberty usually occurs around age

    13 with Hypergonadism, this development occurs

    before age 10

    Signs of precocious sexual developmentinclude:

    growth of a beard and pubic hair

    enlargement of the penis and the testes

    Rapid growth of muscle and bone leads to earlyuniting of the epiphyses and a premature stoppageof growth in the long bones.

  • 8/2/2019 Metab IV Adrenal)

    36/119

    Female

    In the female, onset of puberty, usually occursaround the age of 10

    with hypergonadism, this development occursbefore age 8.

    Signs of precocious sexual developmentinclude:

    onset of menarche

    appearance of pubic and underarm hair

    breast enlargement

    Ovarian development renders the individual fertile,making pregnancy possible.

  • 8/2/2019 Metab IV Adrenal)

    37/119

    Hypogonadism

    condition more prevalent in males in whichthe production of sex hormones and germ

    cells are inadequate.

  • 8/2/2019 Metab IV Adrenal)

    38/119

    Boys: Hypogonadism most often shows up as an

    abnormality in boys during puberty

    Kallmann's syndrome is a birth defect in thebrain that prevents release of hormones andappears as failure of male puberty.

    The childhood disease- Mumps, if acquired

    after puberty, can infect and destroy thetesticlesa disease called viral orchitis

  • 8/2/2019 Metab IV Adrenal)

    39/119

    Ionizing radiation and chemotherapy, trauma,several drugs (spironolactone, a diuretic andketoconazole, an antifungal agent), alcohol,

    marijuana, heroin, methadone, andenvironmental toxins can all damage testiclesand decrease their hormone production.

  • 8/2/2019 Metab IV Adrenal)

    40/119

    Females:

    Female problems in puberty are not causedby too little estrogen. Even female

    reproductive problems are rarely related to asimple lack of hormones, but rather tocomplex cycling rhythms gone wrong. All theproblems with too little hormone happen

    during menopause, which is a normalhypogonadism.

  • 8/2/2019 Metab IV Adrenal)

    41/119

    Manifestations The penis may be small, the testicles undescended

    (cryptorchidism) or various degrees of "feminization"of the genitals may be present.

    Besides the tissue changes generated by hormonestimulation, the only other symptoms relate to sexualdesire and function. Libido is enhanced bytestosterone, and male sexual performance requiresandrogens. The role of female hormones in female

    sexual activity is less clear, although hormonesstrengthen tissues and promote healthy secretions,facilitating sexual activity.

  • 8/2/2019 Metab IV Adrenal)

    42/119

  • 8/2/2019 Metab IV Adrenal)

    43/119

    Treatment:

    Replacement of missing body chemicals.

    Estrogen replacement is recommended for nearly allwomen after menopause for its many beneficialeffects.

    Estrogen can be taken by mouth, injection, or skinpatch. It is strongly recommended that the otherfemale hormone, progesterone, be taken as well,because it prevents overgrowth of uterine lining and

    uterine cancer.

    Testosterone replacement is available for males whoare deficient

  • 8/2/2019 Metab IV Adrenal)

    44/119

    Posterior Pituitary Disorders

    Posterior pituitary dysfunction include specificdisorders involving oversecretion orundersecretion of ADH.

    Diabetes Insipidus, caused by undersecretion ofADH, results in excessive dilute urine production.

    Syndrome of Inappropriate ADH (SIADH),involving oversecretion of ADH, results inexcessive water conservation.

  • 8/2/2019 Metab IV Adrenal)

    45/119

    Etiology

    Diabetes Insipidus

    Posterior pituitary destruction of tumors

    Vascular accidents

    Surgery or hypothalamic damage

    Certain drugs that interfere with ADHsecretion or action (e.g., phenytoin, alcohol,

    lithium carbonate) Nephrologenic diabetes insipidus, familial or

    arising from various renal disorders

  • 8/2/2019 Metab IV Adrenal)

    46/119

    SIADH

    Central nervous system disorders

    Stimulation due to hypoxia or decreased leftatrial filling pressure

    Overuse of vasopressin therapy

    Ectopic ADH production associated withsome cancers

    Nausea or narcotic use, which can stimulateADH secretion

  • 8/2/2019 Metab IV Adrenal)

    47/119

    Pathophysiology

    Diabetes Insipidus occurs when injury to theposterior pituitary gland causes a decrease invasopressin, also known as ADH, secretion oran inability of the kidney tubules to respond toADH.

    In SIADH, the basic pathologic disturbancesare excessive ADH activity, with water

    retention and dilutional hyponatremia, andinappropriate urinary excretion of sodium inthe presence of hyponatremia.

  • 8/2/2019 Metab IV Adrenal)

    48/119

    Assessment Findings

    Clinical Manifestations

    Diabetes Insipidus

    Profoundly increased output (5-20 L/day)

    Nocturia

    Extreme thristWeight loss

    Possible tachycardia, hypotension, andweakness

  • 8/2/2019 Metab IV Adrenal)

    49/119

    SIADH

    Decreased urine output

    Weight gain

    Altered mental status (e.g. headache, confusion,lethargy, seizures, and coma in severehyponatremia)

    Delayed deep tendon reflex

  • 8/2/2019 Metab IV Adrenal)

    50/119

    Laboratory and diagnostic study findings

    Diabetes InsipidusPlasma osmolality and serum sodium levels areelevated

    Water (fluid) deprivation test demonstratesinability of the kidneys to concentrate urinedespite increased plasma osmolality and lowplasma vasopressin level.Vasopressin test demonstrates that the kidneyscan concentrate urine after administration ofADH; this differentiates central (pituitary orhypothalamic) from nephrogenic diabetesinsipidus.

  • 8/2/2019 Metab IV Adrenal)

    51/119

  • 8/2/2019 Metab IV Adrenal)

    52/119

    Nursing Management

    Provide general nursing care for diabetesinsipidus and SIADH.

    Assess dehydration, skin turgor, and mucousmembranes.

    Provide meticulous skin and mouth care.

    Monitor serum electrolyte levels, including sodium

    and potassium.

  • 8/2/2019 Metab IV Adrenal)

    53/119

    Provide specific nursing care for diabetesinsipidus.

    Administer prescribed medications, which

    may include ADH replacements. Replace fluids as indicated. Assess for and

    report any illness, injury, or other problemthat could prevent adequate fluid intake.

    Encourage the client to drink fluids inresponse to thirst. For some unknownreason, the client craves ice cold water.

  • 8/2/2019 Metab IV Adrenal)

    54/119

    Provide specific nursing care for SIADH.Administer prescribed medications, which mayinclude Furosemide (Lasix), to preventconcentration of urine

    Regularly assess mental status.

  • 8/2/2019 Metab IV Adrenal)

    55/119

    Thyroid Gland Disorders

    Hypothyroidismstate of insufficient serum thyroid hormone

    prevalent in persons between 40 and 50 years old

    at least twice as common in women as it is in men.

  • 8/2/2019 Metab IV Adrenal)

    56/119

  • 8/2/2019 Metab IV Adrenal)

    57/119

    Manifestations

    prolonged jaundice after birth, or dry wrinkled skin, aswollen face and tongue that causes noisy respirationand an open mouth that drools

    fingers may be broad, and a small hernia at the bellybutton is quite common

    baby is usually listless, slow-moving, constipated, anda slow feeder

    older children who develop hypothyroidism suddenlystop growing

  • 8/2/2019 Metab IV Adrenal)

    58/119

  • 8/2/2019 Metab IV Adrenal)

    59/119

  • 8/2/2019 Metab IV Adrenal)

    60/119

    Risk Factor

    Age, weight, and medical history

    Women are more likely to develop thedisease after age 50; men, after age 60

    Obesity

    family history

    history of high cholesterol levels

    autoimmune diseases as lupus, rheumatoidarthritis, or diabetes mellitus

  • 8/2/2019 Metab IV Adrenal)

    61/119

    Etiology

    Primary Hypothyroidism results frompathologic changes in the thyroid glandcaused by: Autoimmune thyroids

    Thyroidectomy Radioactive iodine therapy Antithyroid medication therapy

    Secondary Hypothyroidism results from

    failure of the pituitary gland to secreteadequate TSH, possibly because of atumor, surgical removal, or irradiation.

  • 8/2/2019 Metab IV Adrenal)

    62/119

    Laboratory and diagnostic study findings Thyroid function tests reveal decreased T4 and T3

    levels

    Serum TSH test reveal increased TSH (primary).

    Serum antibody tests detects presence of antithyroidantibodies (autoimmune)

    Blood studies reveal elevated cholesterol andcreatine phosphokinase

  • 8/2/2019 Metab IV Adrenal)

    63/119

    Pathophysiology

    Inability of the thyroid gland to secrete sufficient

    amounts of thyroid hormone, (thyroxine regulatessuch essential functions as heart rate, digestion,physical growth, and mental development, aninsufficient supply of this hormone)

    1. leads to decreased cellular metabolic activities2. decreased oxygen consumption

    3. decreased heat production

    these actions produce mild to marked effects in all

    organ systems, can slow life-sustaining processes,damage organs and tissues in every part of the body,and lead to life-threatening complications.

    Assessment

  • 8/2/2019 Metab IV Adrenal)

    64/119

    AssessmentClinical Manifestations Sluggishness, lethargy, depression, apathy, fatigue,

    and exercise intolerance Memory impairment Muscle aches, numbness and tingling of hands Cold intolerance Constipation

    Weight gain and decreased appetite Menstrual irregularities, infertility, and decreased

    libido Dry skin, brittle nails and dry hair Possible goiter Delay in muscle contraction and relaxation of tendon

    reflexes Bradycardia

    M d

  • 8/2/2019 Metab IV Adrenal)

    65/119

    Myxedema coma

    extreme complication of hypothyroidism in whichpatients exhibit multiple organ abnormalities andprogressive mental deterioration

    refers to the swelling of the skin and soft tissuethat occurs in patients who are hypothyroid

    Myxedema coma occurs when the body'scompensatory responses to hypothyroidism areoverwhelmed by a precipitating factor such asinfection.

    The cardinal manifestation of myxedema coma isa deterioration of the patient's mental status.

  • 8/2/2019 Metab IV Adrenal)

    66/119

    Myedema coma

    Hypotension

    Hypoventilation

    HypothermiaStupor, possibly progressing to coma

    N i M t

  • 8/2/2019 Metab IV Adrenal)

    67/119

    Nursing Management

    Provide Pharmacotherapy

    Administer prescribed medications, which mayinclude T4

    Keep in mind that a client with hypothyroidism isvery sensitive to narcotics, anesthetics, and

    sedatives; drug degradation is delayed, andrespiratory depression can develop.

    Instruct the client and family members orsignificant others in the prescribed medication

    regimen, including purpose dosage schedule, andsigns of overreplacement and underreplacement.

  • 8/2/2019 Metab IV Adrenal)

    68/119

    Administer fluids cautiously, because the clientmay not be able to excrete a heavy water load.If the client has hypoglycemia, infuse aconcentrated source of glucose

    Provide relief of constipation, as indicated.

    Prevent vascular collapse in a hypothermicclient. Refrain from aggressive rewarming.

    Institute respiratory assistance whennecessary.

    Implement infection-prevention measures.

  • 8/2/2019 Metab IV Adrenal)

    69/119

    Hyperthyroidism

    metabolic imbalance resulting from excessivethyroid hormone production

    Graves disease- most common form The incidence of Graves disease is greatest

    between the ages of 30-40 and is higheramong women than men.

  • 8/2/2019 Metab IV Adrenal)

    70/119

    Etiology

    Autoimmune dysfunction is the most commoncause of Graves disease; autoantibodiesapparently mimic TSH, leading tohypersecretion of thyroid hormones.

    Genetic factors seem to play a role. Other possible causes include:

    Toxic nodular goiter

    Exposure to iodine

    TSH-secreting pituitary tumor (rare)Thyroiditis, which may be acute, subacute, orchronic (ie, Hashimoto disease)

  • 8/2/2019 Metab IV Adrenal)

    71/119

    Pathophysiology

    Excessive secretion of thyroid hormone- leadsto:

    increased metabolic rateexcessive heat production

    increased responsiveness to catecholamines

    these actions lead to profound changes inmany organ systems.

  • 8/2/2019 Metab IV Adrenal)

    72/119

    Assessment Findings

    Clinical Manifestations

    Nervousness, irritability, hyperactivity, emotionalexcitability, and decreased attention span

    Weakness, easy fatigability, and exercise

    intoleranceHeat intolerance

    Weight change (loss or gain) and increasedappetite

    Insomnia and interrupted sleepFrequent stools and diarrhea

  • 8/2/2019 Metab IV Adrenal)

    73/119

    Menstrual irregularities and decreased libido

    Warm, sweaty, flushed skin with a velvety-smoothtexture and spider telangiectasias

    Tremor, hyperkinesias, and Hyperreflexia

    Exophthalmos, retracted eyelids, and staring gaze

    Hair loss

    Goiter

    Bruits over the thyroid gland

  • 8/2/2019 Metab IV Adrenal)

    74/119

    Thyroid storm:

    Hyperthermia, Hypertension, Delirium,Vomiting and abdominal pain,

    Tachyarrhythmias

  • 8/2/2019 Metab IV Adrenal)

    75/119

  • 8/2/2019 Metab IV Adrenal)

    76/119

    Laboratory and Diagnostic Study Findings

    Serum thyroid function test reveal increased T4 andT3 levels.

    Radioactive iodine uptake test shows an increaseduptake.

    Serum TSH assay reveals a nondetectable TSH level.

    Thyroid scan reveals increased function (i.e., hotareas) in the thyroid gland.

    Nursing Management

  • 8/2/2019 Metab IV Adrenal)

    77/119

    Nursing Management

    Administer prescribed medications

    Assist the client and family members or significant

    others in exploring treatment options. Include familymembers or significant others because the clientsattention span deficit may impair retention ofinformation. Options include:

    Pharmacotherapy with drugs that interfere with thyroidhormone synthesis of release

    Radioactive iodine therapy permanently limits thyroidhormone secretion by destroying thyroid tissue.Hypothyroidism, requiring lifelong replacement therapy

    usually develops at some point after this treatment.Surgery (subtotal or total thyroidectomy). The thyroidlevels must be lowered preoperatively to prevent thyroidstorm; lifelong replacement therapy may be necessary.

  • 8/2/2019 Metab IV Adrenal)

    78/119

  • 8/2/2019 Metab IV Adrenal)

    79/119

    Prevent Injury

    Maintain Normothermia

  • 8/2/2019 Metab IV Adrenal)

    80/119

    Provide post-operative care, if appropriate.Support the head and avoid tension on sutures.

    Monitor for complications and intervene asindicated. Hemorrhage requires the nurse to assess the

    surgical dressing and sides and back of neck forbleeding.

  • 8/2/2019 Metab IV Adrenal)

    81/119

    Parathyroid Gland Disorders

    Hyperparathyroidism

    overproduction of PTH, resulting in high bloodcalcium levels and bone demineralization

    may be primary or secondary Primary hyperparathyroidism is a common

    condition, usually occurring after age 60 andaffecting women more often than men.

  • 8/2/2019 Metab IV Adrenal)

    82/119

    Etiology

    Primary HyperparathyroidismAbout 80% of cases are linked to a single

    adenoma of the parathyroid gland; the remainingcases are caused by parathyroid hyperplasia.

    Secondary hyperparathyroidism results from anadaptive increase in PTH secretion associated

    with problems involving chronic hypocalcemia.

    Assessment Findings

  • 8/2/2019 Metab IV Adrenal)

    83/119

    Assessment Findings

    Clinical Manifestations

    Although hyperparathyroidism may beasymptomatic, it may produce the followingsigns and symptoms:

    Fatigue, muscular weakness, and listlessness

    Height loss and frequent fracturesRenal calculi

    Anorexia, nausea, abdominal discomfort, andconstipation

    Memory impairment

    Polyuria and polydipsia

    Back and joint pain

    Hypertension

  • 8/2/2019 Metab IV Adrenal)

    84/119

    Laboratory and Diagnostic Study Findings Total and ionized serum calcium levels are elevated

    Serum and phosphate levels are decreased

    Urinalysis identifies hypercalciuria andhyperphosphaturia

    Radiograph or bone densitometry detects bonedemineralization

    PTH levels are elevated Parathyroid scan possibly detects abnormal findings

  • 8/2/2019 Metab IV Adrenal)

    85/119

    Nursing ManagementProvide preoperative care.Prepare the client for surgical treatment of primaryhyperparathyroidism, which ,may includeadenoma removal and hyperplastic gland

    resection.Force fluids to prevent dehydration, constipation,and kidney stone formation.Reduce added calcium by eliminating over-the-counter antacids, which may contain calcium;thiazide diuretics, which interfere with renalcalcium excretion; and excessive intake of dairyproducts.

  • 8/2/2019 Metab IV Adrenal)

    86/119

    Provide postoperative care, which is similar tothat for thyroidectomy.

    As indicated, provide aggressive calciumsupplementation after surgery to compensate

    for hungry bone syndrome. Observe the client

    for symptoms of hypercalcemia (e.g., nausea,vomiting, headache, mental confusion,anorexia).

    Assess for renal calculi; report hematuria orflank pain as necessary.

  • 8/2/2019 Metab IV Adrenal)

    87/119

    Take measures to protect the client frominjury.

    Assist with the activities of daily living and

    ambulation as necessary.Encourage weight bearing to reducecalcium loss from the bones.

    Teach strategies to minimize falls, which

    may lead to fractures.

  • 8/2/2019 Metab IV Adrenal)

    88/119

    Provide relief of constipation as indicated; prunejuice, stool softeners, physical activity, andincreased fluids help prevent constipation.

    Monitor nutritional status, and intervene asnecessary. Advise the client to avoid a diet withrestricted or excess calcium.

    Reinforce the health care follow-up scheduled.

  • 8/2/2019 Metab IV Adrenal)

    89/119

    Hypoparathyroidism

    PTH deficiency characterized by

    hypocalcemia, hyperphosphatemia, andneuromuscular hyperexcitability.

  • 8/2/2019 Metab IV Adrenal)

    90/119

    Etiology iatrogenic, caused by accidental removal of or

    trauma to parathyroid glands during thyroidectomy,parathyroidectomy, or radical head or neck surgery.

    autoimmune genetic dysfunction (affects more

    women than men). A reversible form may be associated with

    hypomagnesemia, which interferes with PTHsecretion.

    A Fi di

  • 8/2/2019 Metab IV Adrenal)

    91/119

    Assessment Findings

    Clinical Manifestations

    Anxiety and irritability

    Numbness, tingling, and cramps in extremities

    Dysphagia

    Photophobia Evidence of neuromuscular hyoerexcitability,

    such as positive Chvostek and Trousseausigns, carpopedal spasms, bronchospasms,

    laryngeal spasms, arrhythmias, andconvulsion

  • 8/2/2019 Metab IV Adrenal)

    92/119

    Laboratory and diagnostic study findingsTotal and ionized serum calcium levels are low.

    Serum phosphate level is elevated.

    Serum PTH level is low.

    Nursing Management

  • 8/2/2019 Metab IV Adrenal)

    93/119

    Administer prescribed medications, which includecalcium and vitamin D supplements.

    Intervene for lie-threatening tetany as indicated.

    Administer intravenous calcium gluconateto prevent calcium depletion.

    Be alert for possible laryngeal spasm andresulting respiratory obstructions; keep atracheostomy set available.

    Institute seizure precautions. Providepadded side rails and bite block at

    bedside.Minimize environmental stimuli.

    After the crisis resolves, closely monitorcalcium levels. Keep intravenous calcium

    gluconate in the clients room.

  • 8/2/2019 Metab IV Adrenal)

    94/119

    Provide care in chronic hypoparathyroidism.

    high calcium and low phosphorus diet

    Milk, milk products, and egg yolks must beavoided because they are high in phosphorus.

    Administer vitamin D and magnesiumsupplementation, as indicated. In clients

    receiving magnesium, observe for symptoms ofhypermagnesemia (i.e., hypotension, respiratorydepression, muscle weakness, and confusion.)

    Administer oral calcium preparations to

    supplement the diet.

  • 8/2/2019 Metab IV Adrenal)

    95/119

    Provide client and family teaching about themedication regimen, including purpose,dosage schedule, and signs and symptoms ofhypocalcemia and hypercalcemia. Inform theclient that the dosage will be adjustedperiodically based on the laboratory findings.

    Adrenal Glands Disorders

  • 8/2/2019 Metab IV Adrenal)

    96/119

    Adrenal Glands Disorders

    Cushing Syndrome involves excessive production of

    adrenocortical hormones, primarily cortisol but

    also androgens and mineralocorticoids. Theincident is higher in women than in men.

  • 8/2/2019 Metab IV Adrenal)

    97/119

    Etiology

    The most common cause of CushingSyndrome is bilateral adrenal hyperplasia (i.e.,Cushing disease).

    Other causes include: Adrenal adenomas and carcinoma

    Ectopic ACTH production by tumors in otherorgans, such as the lungs and pancreas.

    Glucocorticoid therapy

    Assessment Findings

    Clinical Manifestations depend on the

  • 8/2/2019 Metab IV Adrenal)

    98/119

    Clinical Manifestations depend on theadrenocortical hormones involved and mayinclude:

    Weight gain and altered fat distribution (e.g., centralobesity with round [moon] face and buffalo hump.

    Muscle weakness, proximal muscle wasting, and fatigue

    Frequent infections and poor wound healing

    Symptoms of hyperglycemia Mental status changes and mood swings

    Menstrual disturbances, such as amenorrhea

    Diminished libido

    Skin changes, such as striae, bruises, acne, andthinning of scalp hair

    Hypertension

    Hirsutism

    Susceptibility to compression fractures

    Edema

  • 8/2/2019 Metab IV Adrenal)

    99/119

    Laboratory Findings Serum potassium level is decreased.

    Serum glucose level is elevated.

    WBC count reveals depressed eosinophiland lymphocyte counts.

    Diurnal variation plasma levels revealelevated plasma cortisol and 24-hour urine

    cortisol results.

  • 8/2/2019 Metab IV Adrenal)

    100/119

    Results for the 24-hour urinary free cortisollevel and 24-hour urine collection for 17-

    hydrocorticosteriods and 17-ketosteroids areelevated.

    Selected radiographic and axial CT studiesmay determine the site if ectopic ACTH

    production

    N i M t

  • 8/2/2019 Metab IV Adrenal)

    101/119

    Nursing Management

    Administer prescribed medications, which mayinclude adrenocortical steroid inhibitors.Take measures to protect the client from injuryand infection.

    Assess skin integrity regularly. Avoid agents that can damage skin (e.g., tape,

    strong soaps) Promote good hygiene. Modify the environment to remove or minimize

    hazards.

  • 8/2/2019 Metab IV Adrenal)

    102/119

    Prepare the client for surgery, if indicated. Keep in mindthat any treatment modality can cause temporary

    adrenal insufficiency. Procedures may include:Adrenalectomy, if the cause is adrenaladenoma

    Transsphenoidal hypophysectomy, if the cause

    is pituitary adenomaTumor resection

    Encourage the client and family to ask questions andverbalize concerns about disease pathology, body

    image, treatment, and mental status.

  • 8/2/2019 Metab IV Adrenal)

    103/119

    Addison disease

    a primary adrenal hypofunction due tohyposecretion of adrenal cortex hormones.

  • 8/2/2019 Metab IV Adrenal)

    104/119

    Etiology

    Addison Disease can result from:

    An autoimmune process

    Hemorrhage into the adrenal gland

    Adrenalectomy

    Neoplasm

    Fungal infection

    Tuberculosis

  • 8/2/2019 Metab IV Adrenal)

    105/119

    Assessment Findings

    Clinical Manifestations Addison disease

    Gastrointestinal complaints such as anorexia,nausea, vomiting, abdominal pain, and diarrhea

    Fatigue, muscle weakness, and arthralgias Decreased alertness and confusion

    Weight loss

    Dry skin, decreased body hair, and possible

    increased pigmentation with excessive ACTHstimulation

  • 8/2/2019 Metab IV Adrenal)

    106/119

    Addisonian (adrenal) CrisisHypotension

    Rapid, weak pulse

    Rapid respiratory rate

    Pallor and extreme weakness

    Hyperthermia

  • 8/2/2019 Metab IV Adrenal)

    107/119

    Laboratory and Diagnostic Study Findings Suggestive Findings

    Serum blood glucose is decreased.

    Serum sodium level is decreased.

    Serum potassium level is increased.

    WBC cell count is increased.

    Definitive Findings

    Serum cortisol levels are decreased.ACTH stimulation test reveals a low to normalcortisol response.

    N i M t

  • 8/2/2019 Metab IV Adrenal)

    108/119

    Nursing Management

    Administer prescribed medications, whichmay include glucocorticosteroids andmineralocorticosteroids.

    Provide immediate treatment for an

    addisonian crisis. Treatment includesintravenous fluid, glucose, and electrolytes.Corticosteroid replacement andvasopressors may be administered. The

    client must avoid exertion.

  • 8/2/2019 Metab IV Adrenal)

    109/119

    Help prevent adrenal crisis. Instruct the client to take precautions to

    avoid unnecessary activity and events that

    may be stressful. Ensure that hospitalized, acutely ill clients

    on a long-term glucocorticoid therapyreceive additional doses to compensate for

    stress.

  • 8/2/2019 Metab IV Adrenal)

    110/119

    Provide client and family teaching.

    Discuss hormone therapy, including its purpose,side effects, duration, symptoms of abnormalities toreport to health care manager, and the need toinform all health care providers about the steroid

    replacement therapy. If overreplacement of glucocorticoids is indicated,

    inform the client about the purpose of therapy andpossible side effects, such as cushingoidappearance, weight gain, acne, hirsutism, peptic

    ulcer, diabetes mellitus, osteoporosis, infection,muscular weakness, mood swings, cataracts, andhypertension.

  • 8/2/2019 Metab IV Adrenal)

    111/119

    Pheochromocytoma a tumor that is usually benign and originiates

    from the chromaffin cells of the adrenal

    medulla.

  • 8/2/2019 Metab IV Adrenal)

    112/119

    peak incidence is ages 20-50 years 10% of the tumors are bilateral; 10% are

    malignant

    stimulates hypersecretion of catecholamines(epinephrine and norepinephrine)

    SNS overactivity causing the five Hs:

    hypertension, headache, hyperhidrosis,

    hypermetabolism, hyperglyclemia

    Diagnostic Exams

  • 8/2/2019 Metab IV Adrenal)

    113/119

    Total Plasma Catecholamine Concentration

    the client should lie supine and rest for 30minutes

    butterfly needle is inserted 30 minutes beforeblood specimen is collected (to prevent elevation

    of catecholamine levels by the stress ofvenipuncture)

    normal values:Epinephrine: 100 pinogram/ml (590 pmol/L)

    Epinephrine: 100 to 550 pinogram/ml (590-3240pmol/L)

  • 8/2/2019 Metab IV Adrenal)

    114/119

    Clonidine Suppression Test

    Clonidine (Catapress) a centrally actingadrenergic blocker suppresess the release ofcatocholamines.

    in pheochromocytoma, clonidine does not

    suppress the release of catecholamines Normal response: 2-3 hours after a single oral

    dose of clonidine, the total plasmacatecholamine value decreases at least 40%

    from the clients baseline.

  • 8/2/2019 Metab IV Adrenal)

    115/119

    CT scan, MRI, and Ultrasound to localize the pheochromacytoma

  • 8/2/2019 Metab IV Adrenal)

    116/119

    Collaborative Management

    Medical Management Bed rest, head of bed elevated during episode

    of hypertension, tachycardia, and anxiety toprovide orthostatic decrease in BP.

    Pharmacologic therapy

    Phentolamine (Regitine)

    Sodium Nitroprusside (Nipride) to lower BP quickly

  • 8/2/2019 Metab IV Adrenal)

    117/119

    Surgery Adrenalectomy

    Removal of single glands requires

    corticosteroid therapy for the first few days orweeks postoperatively

    Bilateral removal requires lifetimecorticosteroid therapy

  • 8/2/2019 Metab IV Adrenal)

    118/119

    Nursing Management Teaching the Client Self-Care

    Emphasize the importance of periodic follow-up

    care.Provide instructions on corticosteroid therapy.

    Teach the client and family on how to measure theclients BP.

  • 8/2/2019 Metab IV Adrenal)

    119/119

    End of Chapter!